Tour |
Match |
Score |
Plc |
IC |
ADV |
Top |
Pts |
% |
ic |
adv |
plc |
nég |
% |
1
| PHEa-SABc |
45.0-33.0 |
2 |
11.0 |
0.0 |
741 |
-19
|
97.44 |
|
|
x
|
|
|
|
x
|
|
x
|
|
2
| PHEa-KAKb |
40.0-38.0 |
6 |
7.0 |
3.0 |
931 |
-167
|
82.06 |
|
|
|
x
|
|
|
|
x
|
|
x
|
3
| HYAb-PHEa |
39.0-39.0 |
2 |
11.0 |
0.0 |
801 |
-44
|
94.51 |
|
|
x
|
|
|
|
|
|
|
|
4
| LAPa-PHEa |
33.0-45.0 |
2 |
11.0 |
1.0 |
1018 |
-40
|
96.07 |
|
|
|
|
|
|
|
|
|
|
5
| PHEa-ACJb |
40.5-37.5 |
4 |
9.0 |
2.0 |
859 |
-68
|
92.08 |
|
|
|
|
|
|
|
|
|
|
7
| SABc-PHEa |
36.5-41.5 |
1 |
12.0 |
0.0 |
826 |
-77
|
90.68 |
x
|
|
x
|
|
x
|
|
|
|
|
|
8
| KAKb-PHEa |
34.0-44.0 |
3 |
10.0 |
1.0 |
933 |
-158
|
83.07 |
|
|
|
|
|
|
|
|
|
|
9
| PHEa-HYAb |
50.0-28.0 |
7 |
6.0 |
2.0 |
920 |
-112
|
87.83 |
|
x
|
|
|
|
x
|
|
|
|
|
10
| PHEa-LAPa |
38.0-40.0 |
1 |
12.0 |
0.0 |
798 |
-51
|
93.61 |
x
|
|
x
|
|
x
|
|
|
|
|
|
11
| ACJb-PHEa |
33.0-45.0 |
1 |
12.0 |
0.0 |
1018 |
-90
|
91.16 |
x
|
|
x
|
|
x
|
|
|
|
|
|